Because dopamine itself does not naturally cross into the brain, it is often administered as levodopa (or L- Dopa), which passes into the brain where it is transformed into dopamine. Levodopa is usually given as a tablet or capsule.

Levodopa is highly effective in controlling most symptoms of Parkinson’s disease.
More than 30 years after its discovery it remains the cornerstone of Parkinson’s disease therapy, and a large majority of patients receive levodopa therapy.

Failure to respond to levodopa may suggest that the disorder is not typical Parkinson’s disease, but a Parkinson’s disease- like disorder, and further medical assessments may be required.

Once in the body, levodopa is broken down by molecules called enzymes – this reduces the amount of medication that can reach where it is needed in the brain.

There are two main enzymes involved in the breakdown of levodopa: Peripheral dopa- decarboxylase (DDC) and catechol- O- methyltransferase (COMT).

Inhibiting these enzymes can prevent levodopa’s breakdown, optimizing it’s availability in the brain and improving symptom control. Unfortunately the effectiveness of levodopa can decline after years of treatment.

TOP